Published in J Transl Med on January 20, 2016
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 8.87
The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36
The microRNA spectrum in 12 body fluids. Clin Chem (2010) 6.82
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol (2003) 6.27
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood (2010) 5.79
Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest (2011) 5.75
Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med (2009) 5.26
Calories do not explain extension of life span by dietary restriction in Drosophila. PLoS Biol (2005) 4.30
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet (2007) 3.93
Delayed graft function in kidney transplantation. Lancet (2004) 3.06
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet (2011) 2.82
Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant (2011) 2.69
Renal transplantation after ex vivo normothermic perfusion: the first clinical study. Am J Transplant (2013) 2.36
MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A (2009) 2.36
Organ donation and utilization in the United States, 1999-2008. Am J Transplant (2010) 2.33
Effect of calorie restriction with or without exercise on body composition and fat distribution. J Clin Endocrinol Metab (2007) 2.33
Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A (2010) 2.31
Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A (2008) 2.21
Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol (2009) 2.18
Protection against renal ischemia-reperfusion injury by ischemic postconditioning. Transplantation (2013) 2.17
Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med (2005) 1.92
Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol (2010) 1.87
Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation (2004) 1.82
Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy. J Gerontol A Biol Sci Med Sci (2010) 1.80
Surgical stress resistance induced by single amino acid deprivation requires Gcn2 in mice. Sci Transl Med (2012) 1.78
Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med (2011) 1.75
Restriction of amino acids extends lifespan in Drosophila melanogaster. Mech Ageing Dev (2006) 1.73
Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab (2003) 1.72
Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med (2013) 1.68
Living unrelated donor kidney transplantation. Kidney Int (2000) 1.61
Glucose supplementation does not interfere with fasting-induced protection against renal ischemia/reperfusion injury in mice. Transplantation (2011) 1.57
Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis. PLoS One (2012) 1.56
Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc (2008) 1.53
The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol (2011) 1.53
Ischemic postconditioning attenuates renal ischemic/reperfusion injury in mongrel dogs. Urology (2010) 1.53
Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model. Nephrol Dial Transplant (2010) 1.52
The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med (Berl) (2009) 1.49
Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice. Aging Cell (2009) 1.47
Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol (2006) 1.47
Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR. Biochem J (2013) 1.46
How important is the duration of the brain death period for the outcome in kidney transplantation? Transpl Int (2010) 1.40
Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. Transpl Immunol (2008) 1.40
A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis (2008) 1.37
Activation of mitochondrial apoptotic pathways in human renal allografts after ischemiareperfusion injury. Transplantation (2003) 1.35
Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol (2009) 1.29
Publication bias in laboratory animal research: a survey on magnitude, drivers, consequences and potential solutions. PLoS One (2012) 1.23
Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int Immunopharmacol (2009) 1.17
Benefits of short-term dietary restriction in mammals. Exp Gerontol (2013) 1.16
Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury. Nephron Exp Nephrol (2009) 1.16
Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats. Biotechnol Lett (2010) 1.09
Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. Transplantation (2013) 1.07
Mesenchymal stem cells induce an inflammatory response after intravenous infusion. Stem Cells Dev (2013) 1.07
Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis (2003) 1.06
Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets (2009) 1.02
Comparison of kidney function between donation after cardiac death and donation after brain death kidney transplantation. Transplantation (2013) 0.99
First report of the protective effects of remote per- and postconditioning on ischemia/reperfusion-induced renal injury. Transplantation (2011) 0.99
Tolerance: of mice and men. J Clin Invest (2003) 0.99
Attenuation of renal ischemia-reperfusion injury by postconditioning involves adenosine receptor and protein kinase C activation. Transpl Int (2009) 0.99
Long-term inhibition of myocardial infarction by postconditioning during reperfusion. Basic Res Cardiol (2006) 0.97
The metabolic effects of fasting and surgery. Best Pract Res Clin Anaesthesiol (2006) 0.95
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrol Dial Transplant (2006) 0.95
Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury. Acta Physiol (Oxf) (2013) 0.94
Postischemic renal injury due to oxygen radicals. Curr Opin Nephrol Hypertens (1993) 0.94
Erythropoietin: ready for prime-time cardioprotection. Trends Pharmacol Sci (2008) 0.94
Remote ischemic conditioning enhanced the early recovery of renal function in recipients after kidney transplantation: a randomized controlled trial. J Surg Res (2013) 0.94
The potential role of statins in contrast nephropathy. Clin Nephrol (2004) 0.93
Regulatory T cells in AKI. J Am Soc Nephrol (2013) 0.92
Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats. Transplant Proc (2013) 0.92
Ischemic postconditioning inhibits the renal fibrosis induced by ischemia-reperfusion injury in rats. Urology (2012) 0.91
Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols. Urology (2003) 0.91
Protection of organs other than the heart by remote ischemic conditioning. J Cardiovasc Med (Hagerstown) (2013) 0.90
Influence of delayed graft function and acute rejection on outcomes after kidney transplantation from donors after cardiac death. Transplantation (2012) 0.90
A novel proteolysis-resistant cyclic helix B peptide ameliorates kidney ischemia reperfusion injury. Biochim Biophys Acta (2014) 0.90
The evidence base behind modern fasting guidelines. Best Pract Res Clin Anaesthesiol (2006) 0.89
Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney. Nephron Physiol (2007) 0.89
Time-dependent changes in donor brain death related processes. Am J Transplant (2006) 0.88
Mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal dysfunction by improving the antioxidant/oxidant balance in the ischemic kidney. Urol Int (2010) 0.88
The need to reduce cold ischemia time in kidney transplantation. Curr Opin Organ Transplant (2013) 0.88
Pre-operative dietary restriction is feasible in live-kidney donors. Clin Transplant (2010) 0.87
Ischemic postconditioning in human DCD kidney transplantation is feasible and appears safe. Transpl Int (2013) 0.85
Evaluation of the effect of autologous mesenchymal stem cell injection in a large-animal model of bilateral kidney ischaemia reperfusion injury. Cell Prolif (2009) 0.85
Chronic allograft nephropathy. Pediatr Nephrol (2008) 0.85
Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment. J Transl Med (2012) 0.85
Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions. Cytotherapy (2013) 0.85
Machine perfusion versus cold storage of kidneys derived from donation after cardiac death: a meta-analysis. PLoS One (2013) 0.84
Normothermic machine perfusion of the kidney: better conditioning and repair? Transpl Int (2014) 0.84
Do statins prevent acute kidney injury? Expert Opin Drug Saf (2015) 0.82
Protective effects of three remote ischemic conditioning procedures against renal ischemic/reperfusion injury in rat kidneys: a comparative study. Ir J Med Sci (2014) 0.82
Donation from old living donors: how safe is it? Nephrol Dial Transplant (2013) 0.81
UW is superior compared with HTK after prolonged preservation of renal grafts. J Surg Res (2011) 0.81
Outcomes in renal transplantation with expanded-criteria donors. Transplant Proc (2013) 0.81
Hypothermic machine perfusion of kidneys retrieved from standard and high-risk donors. Transpl Int (2015) 0.80
Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and Celsior. Transplantation (2002) 0.80
Obesity as a barrier to living kidney donation: a center-based analysis. Clin Transplant (2013) 0.80
Delayed graft function does not harm the future of donation-after-cardiac death in kidney transplantation. Transplant Proc (2012) 0.79
Preservation strategies to reduce ischemic injury in kidney transplantation: pharmacological and genetic approaches. Curr Opin Organ Transplant (2011) 0.79